跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xultophy - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xultophy
Approved
STANDARD
Xultophy
Novo Nordisk A/S
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7cd32e4cfce2c594
Company
Novo Nordisk A/S
Type
Standard
Approval Details
Approval Id
7cd32e4cfce2c594
Drug Approval Philippines Name
Xultophy
Product Name
Xultophy
Registration Number
BR-1225
Brand Name
Xultophy
Generic Name
Insulin Degludec + Liraglutide
Dosage Form
Solution for Injection (SC)
Dosage Strength
100 U/3.6 mg/mL
Manufacturer
Novo Nordisk A/S
Importer
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Distributor
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Company Detail Path
/organization/novo-nordisk-a-s
Issuance Date
24 October 2022
Expiry Date
10 August 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7cd32e4cfce2c594
Type
Standard
Back to Philippines FDA Approvals